Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

3(38%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_4

50%

Ph phase_1

25%

Ph phase_3

13%

Ph not_applicable

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution8 total trials

Phase 1Safety & dosage

2(25.0%)

Phase 3Large-scale testing

1(12.5%)

Phase 4Post-market surveillance

4(50.0%)

N/ANon-phased studies

1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Completed(2)

Other(2)

Detailed Status

Recruiting3

unknown2

Completed2

Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 12 (25.0%)

Phase 31 (12.5%)

Phase 44 (50.0%)

N/A1 (12.5%)

Trials by Status

not_yet_recruiting113%

unknown225%

completed225%

recruiting338%

Recent Activity

3 active trials

Showing 5 of 8

recruitingphase_4

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

NCT06538077

recruitingphase_4

Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct

NCT05677282

completedphase_4

A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing

NCT03219528

recruitingnot_applicable

Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant

NCT06743464

not_yet_recruitingphase_1

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

NCT06783153

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06538077Phase 4

BCAA vs. Rifaximin in Patients With Cirrhosis for Secondary Prophylaxis of HE

Recruiting

NCT05677282Phase 4

Single Dose Antibiotic Treatment of Acute Watery Diarrhea, Rifaximin Versus Azithromycin, With Loperamide Adjunct

Recruiting

NCT03219528Phase 4

A Longitudinal Study to Identify IBS Phenotypes Using Fecal Microbiota and Hydrogen Breath Testing

Completed

NCT06743464Not Applicable

Effect of Perioperative Oral Rifaximin on Early Graft Dysfunction in Adult Living Donor Liver Transplant

Recruiting

NCT06783153Phase 1

Efficacy and Safety of Adjunctive Use of Rifaximin In Preventing Radiotherapy-induced Diarrhea in Cancer Patients

Not Yet Recruiting

NCT05867550Phase 4

To Compare the Efficacy of Drugs in Combination for Treating Irritable Bowel Syndrome Associated With Diarrhea

Completed

NCT03958708Phase 1

Modulation of Gut Microbiota by Rifaximin in PD Patients

Unknown

NCT03658993Phase 3

Rifaximin-treatment of Collagenous Colitis

Unknown

All 8 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 8